Antonio I Picon1, Daniel G Coit1, Ashok R Shaha2, Mary S Brady1, Jay O Boyle2, Bhuvanesh B Singh2, Richard J Wong2, Klaus J Busam3, Jatin P Shah2, Dennis H Kraus4. 1. Gastric and Mixed Tumors Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, 10021. 2. Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, P.O. Box 285, New York, New York, 10021. 3. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, 10021. 4. Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, P.O. Box 285, New York, New York, 10021. krausd@mskcc.org.
Abstract
BACKGROUND: Sentinel lymph node biopsy (SLNB) for primary cutaneous head and neck melanoma (CHNM) has been shown to be successful and is the current standard of care for intermediate-thickness melanoma. We evaluated our experience with CHNM associated with SLNB mapping to the region of the parotid gland. METHODS: Retrospective review of a prospectively collected melanoma database identified 1014 CHNMs. Two-hundred twenty-three patients underwent SLNB, and 72 (32%) had mapping in the region of the parotid gland between May 1995 and June 2003. RESULTS: The mean number of SLNs per patient was 2.5. A sentinel lymph node (SLN) was successfully identified in 94% of patients, and in 12%, the SLN was positive for metastatic disease. Biopsy of intraparotid SLNs was performed in 51.4% and of periparotid SLNs in 26.4%, and a superficial parotidectomy was performed in 22.2%. Ten patients were found to have lymph nodes in the parotid region with metastatic disease (eight identified by SLNB), and two (20%) patients developed intraparotid lymph node recurrence in the setting of a negative SLNB. Same-basin recurrence in SLN-negative patients was 3.3% with a median follow-up of 26 months. Facial nerve dysfunction was identified in seven (10%) patients. Facial nerve function returned to preoperative status in all patients. CONCLUSIONS: SLNB for patients with primary CHNM mapping to the parotid gland can be performed with a high degree of accuracy and a low morbidity consisting of temporary facial nerve paresis.
BACKGROUND: Sentinel lymph node biopsy (SLNB) for primary cutaneous head and neck melanoma (CHNM) has been shown to be successful and is the current standard of care for intermediate-thickness melanoma. We evaluated our experience with CHNM associated with SLNB mapping to the region of the parotid gland. METHODS: Retrospective review of a prospectively collected melanoma database identified 1014 CHNMs. Two-hundred twenty-three patients underwent SLNB, and 72 (32%) had mapping in the region of the parotid gland between May 1995 and June 2003. RESULTS: The mean number of SLNs per patient was 2.5. A sentinel lymph node (SLN) was successfully identified in 94% of patients, and in 12%, the SLN was positive for metastatic disease. Biopsy of intraparotid SLNs was performed in 51.4% and of periparotid SLNs in 26.4%, and a superficial parotidectomy was performed in 22.2%. Ten patients were found to have lymph nodes in the parotid region with metastatic disease (eight identified by SLNB), and two (20%) patients developed intraparotid lymph node recurrence in the setting of a negative SLNB. Same-basin recurrence in SLN-negative patients was 3.3% with a median follow-up of 26 months. Facial nerve dysfunction was identified in seven (10%) patients. Facial nerve function returned to preoperative status in all patients. CONCLUSIONS: SLNB for patients with primary CHNM mapping to the parotid gland can be performed with a high degree of accuracy and a low morbidity consisting of temporary facial nerve paresis.
Authors: Snehal G Patel; Daniel G Coit; Ashok R Shaha; Mary Sue Brady; Jay O Boyle; Bhuvanesh Singh; Jatin P Shah; Dennis H Kraus Journal: Arch Otolaryngol Head Neck Surg Date: 2002-03
Authors: L Jansen; H S Koops; O E Nieweg; M H Doting; B A Kapteijn; A J Balm; A Vermey; J T Plukker; C A Hoefnagel; D A Piers; B B Kroon Journal: Head Neck Date: 2000-01 Impact factor: 3.147
Authors: K E Wells; D P Rapaport; C W Cruse; W Payne; J Albertini; C Berman; G H Lyman; D S Reintgen Journal: Plast Reconstr Surg Date: 1997-09 Impact factor: 4.730
Authors: A S Coates; C I Ingvar; K Petersen-Schaefer; H M Shaw; G W Milton; C J O'Brien; J F Thompson; W H McCarthy Journal: J Am Coll Surg Date: 1995-04 Impact factor: 6.113
Authors: Timothy R Fincher; John C O'Brien; Todd M McCarty; Tammy L Fisher; John T Preskitt; Zelig H Lieberman; Jeffrey F Stephens; Joseph A Kuhn Journal: Arch Otolaryngol Head Neck Surg Date: 2004-07